GBA1 and Parkinson disease: Decreased protein levels and enzymatic activity of GCase were found in affected brain regions [15–18], dried blood spots [19], fibroblasts [20], peripheral blood mononuclear cells [21], and CSF [22–24] of PD patients with GBA mutations, but also in sporadic PD patients.